These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1969772)

  • 41. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat?
    Clark KL; Robertson MJ; Drew GM
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR; Wang PH; Zhang WF; Fennell WH
    Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fenoldopam: potential clinical applications in heart surgery].
    Shorten GD
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):487-91. PubMed ID: 11792308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of dietary protein on the renal response to fenoldopam in diabetic rats.
    Wang YX; Brooks DP
    Eur J Pharmacol; 1993 Oct; 248(3):217-21. PubMed ID: 7904943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
    Hackman BB; Griffin B; Mills M; Ramanathan KB
    Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
    Hedge SS; Ricci A; Amenta F; Lokhandwala MF
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase in plasma renin activity evoked by fenoldopam in dogs is directly mediated by dopamine1 receptor stimulation.
    Montier F; Katchadourian P; Pratz J; Cavero I
    J Cardiovasc Pharmacol; 1989 May; 13(5):739-47. PubMed ID: 2472522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
    Eades SC; Moore JN
    Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of fenoldopam on cecal blood flow and mechanical activity in horses.
    Clark ES; Moore JN
    Am J Vet Res; 1989 Nov; 50(11):1926-30. PubMed ID: 2575878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
    Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
    J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs.
    Hennes HJ; Jantzen JP
    J Neurosurg Anesthesiol; 1994 Jul; 6(3):175-81. PubMed ID: 7915922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
    Andrés A; García-Robles R; Alcázar JM; Alvarez C; Martínez J; Oliet A; Sancho J; Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1989 Dec; 7(6):S326-7. PubMed ID: 2576671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
    Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
    Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
    Francis GS; Wilson BC; Rector TS
    Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of hemodynamic tolerance from a 24-hour intravenous infusion of fenoldopam mesylate in congestive heart failure.
    Munger MA; Benotti JR; Green JA; Jarvis RC; Nara AR; McCue JE; Pospisil RA; Kasmer RJ
    Am J Cardiol; 1990 Jan; 65(3):206-10. PubMed ID: 1967511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.